| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 32 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 32 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 32 |
| 3 | ETOPOSIDE | 31 |
| 4 | DOXORUBICIN | 20 |
| 5 | IFOSFAMIDE | 16 |
| 6 | IFOSFAMIDE FOR INJECTION | 16 |
| 7 | CARBOPLATIN | 13 |
| 8 | METHOTREXATE | 11 |
| 9 | METHOTREXATE SODIUM | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXRAZOXANE FOR INJECTION | 5 | 0.0053 |
| 1 | GRANULOCYTE COLONY STIMULATING FACTOR | 2 | 0.0009 |
| 2 | DACTINOMYCIN | 2 | 0.0009 |
| 3 | IFOSFAMIDE FOR INJECTION | 16 | 0.0007 |
| 4 | MESNA INJECTION | 6 | 0.0007 |
| 5 | MESNA | 6 | 0.0007 |
| 6 | ETOPOSIDE | 31 | 0.0004 |
| 7 | TOPOTECAN HYDROCHLORIDE | 1 | 0.0004 |
| 8 | DEFIBROTIDE SODIUM | 1 | 0.0003 |
| 9 | BRIGATINIB | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 2 | 0.0009 |
| 1 | Topoisomerase Inhibitor [EPC] | 31 | 0.0004 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 5 | 0.0002 |
| 3 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 8 | 0.0001 |
| 4 | Alkylating Drug [EPC] | 33 | 0.0001 |
| 5 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 6 | Platinum-based Drug [EPC] | 18 | 0.0001 |
| 7 | alpha-Adrenergic Blocker [EPC] | 9 | 0.0001 |
| 8 | Aldosterone Antagonist [EPC] | 9 | 0.0001 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 9 | 0.0000 |